Insulet | PODD - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 14.16M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Avanos Medical USD 131.2M 34M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cardinal Health USD 41.99B 1.33B 2026-03
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
ICU Medical USD 517.9M 19.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Roche Holding CHF 28B 421M 2025-12
Solventum Corp USD 3.35B 210M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
West Pharmaceutical Services USD 674M 19.1M 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03